Advertisement

Topics

Partnership Aims to Commercialize Ready-to-Use Infusion Products Overseas

06:50 EDT 23 Aug 2017 | PharmPro

STADA Australia and BioQ Pharma enter into strategic partnership to commercialize three ready-to-use infusion products. The plan includes an opioid sparing post-surgical pain management therapy and two other product candidates.
Contributed Author: 
BioQ Pharma Incorporated
Topics: 

Original Article: Partnership Aims to Commercialize Ready-to-Use Infusion Products Overseas

NEXT ARTICLE

More From BioPortfolio on "Partnership Aims to Commercialize Ready-to-Use Infusion Products Overseas"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...